Professor Stone has substantial experience in interactions with the pharmaceutical industry.
He has acted as a Consultant for existing research projects and an Advisor in the development of new pharmacological approaches to disorders of the CNS  and its treatment

From 1996 to 2006 he was Co-director of the organisation PharmaLinks which promoted academic research to pharmaceutical companies worldwide, though with a special personal interest in Japan.